Nifty Pharma Prediction for Tomorrow, 12 November 2026 (Including F&O)

This nifty pharma prediction for tomorrow follows a Wednesday, 11 November 2026 session in which Nifty Pharma fell 0.41 percent to 28,776.45 after opening at 29,187.55, almost exactly at its high of 29,187.65, and closing about 144 points above its low of 28,632.35.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are tracking sector-specific triggers and F&O positioning ahead of Thursday's session, the next regular trading day after Wednesday's close.

Click Here – Get Free Investment Predictions

What Wednesday Told Us

• Nifty Pharma fell 0.41 percent to 28,776.45, with a high of 29,187.65 and a low of 28,632.35.
• Nifty 50 rose 0.84 percent to 25,255.05.
• India VIX rose 0.92 percent to 17.58.
• Most active among the stocks Univest tracked: HDFC Bank (about 56.4 million shares), ICICI Bank (about 29.2 million) and ONGC (about 26.3 million).

Nifty Pharma Prediction for Tomorrow: Key Levels

Nifty Pharma traded between 28,632.35 and 29,187.65 on Wednesday, against a previous close of 28,896.10, and settled at 28,776.45. On the downside, 28,632.35 is the first reference level to watch if the day's move is tested. On the upside, 28,896.10, 29,187.55 and 29,187.65 mark the nearest resistance. Univest's analysts treat these as reference points drawn from Wednesday's trading range, not as targets.

Trend	Support	Resistance
Negative	28,632.35	28,896.10, 29,187.55, 29,187.65

The index level is the headline number for this note, and the change is measured against Monday's close.

For traders, the nifty pharma prediction for tomorrow is a framework for planning risk, with position size and stop levels left to the individual.

Key Drivers for Thursday

• Nifty Pharma fell 0.41 percent, with a high of 29,187.65 and a low of 28,632.35.
• The index opened about 291 points above the previous close and could not hold the gap.
• The fall came after a rise of 1.65 percent on Monday, so Wednesday looks like profit-taking.

Ankit Jaiswal and Kunal Singla suggest revisiting this nifty pharma prediction for tomorrow after the first thirty minutes of Thursday's trade.

Anyone following the nifty pharma prediction for tomorrow should keep the opening range in view before reading too much into early moves.

Nothing in this nifty pharma prediction for tomorrow is a promise of returns, and every level quoted can fail.

Stocks and Triggers to Watch in the Nifty Pharma Space

Pharma is a traditional defensive sector, and its fall on a day when the Nifty 50 rose 0.84 percent is a sign that money moved toward banks and autos. Traders follow US drug pricing commentary, regulatory approvals and the rupee.

In the F&O segment, the Nifty options data Univest checked shows the nearest expiry on 17 November 2026. Call open interest was highest at the 25,500 strike and put open interest at the 25,000 strike, with a put-call ratio of approximately 0.77, which means call open interest is larger than put open interest. India VIX rose 0.92 percent to 17.58. Univest's analysts treat these strikes as reference points for the broader market, not as predictions for Nifty Pharma.

In short, the nifty pharma prediction for tomorrow rests on Wednesday's verified close and the overnight risks listed below.

These are educational views, not buy calls, and each should be checked against your own risk plan before acting.

How Wednesday's Broader Session Unfolded

The Nifty 50 closed at 25,255.05 on Wednesday, up 0.84 percent from Monday's close of 25,044.65, in the first regular session after Tuesday's Diwali Balipratipada holiday. It opened with a gap-up at 25,337.80, touched a high of 25,424.35, dipped to 25,095.35 and finished about 169 points below the high. The Sensex closed at 81,879.40, up 0.95 percent, while the Bank Nifty closed at 60,792.40, up 1.76 percent, about 602 points below its high of 61,394.30. Nifty Next 50 rose 0.96 percent, Nifty Midcap 50 rose 0.93 percent and the Nifty 500 rose 0.90 percent, so the rise was broad rather than limited to the heavyweights. Nifty PSU Bank jumped 2.94 percent and Nifty Auto rose 2.14 percent, while Nifty IT fell 0.53 percent and Nifty Pharma fell 0.41 percent. India VIX, the market's fear gauge, rose 0.92 percent to 17.58 from 17.42, after trading between 15.64 and 17.83 during the day. In the options market, the Nifty put-call ratio was approximately 0.77, with call open interest highest at the 25,500 strike and put open interest highest at 25,000, for the 17 November expiry. The trigger for Wednesday's moves was not independently confirmed.

Placed against that backdrop, the nifty pharma prediction for tomorrow reads Wednesday's move in the context of a broader market that closed higher.

Analyst View for Thursday

Kunal Singla suggests that Nifty Pharma needs to hold above 28,632.35, Wednesday's low, while a close above 28,896.10 would improve the tone.

Ankit Jaiswal flags that an open at the high followed by a fall is a reversal signal, and the 29,187 level is the ceiling to clear.

Both analysts stress that the nifty pharma prediction for tomorrow is a view built on levels and data, not a forecast of returns.

A fair reading of this nifty pharma prediction for tomorrow is that Wednesday's data sets the context, while Thursday's first hour decides how much of it carries forward.

Why This Is Written for Tomorrow

This nifty pharma prediction for tomorrow is written on Wednesday, 11 November 2026, after the close, using today's closing data, for the next regular trading session tomorrow, Thursday, 12 November 2026. NSE and BSE reopened today after Tuesday's closure for Diwali Balipratipada, and tomorrow is a regular session with no exchange holiday.

Because the equity market is shut for the day, the nifty pharma prediction for tomorrow relies on Wednesday's close rather than any live price.

Overseas markets and currency moves overnight can open Thursday with a gap in either direction. Treat this as a briefing to prepare for the session, not a live call that updates through the day.

Track the Nifty Pharma Space on Univest Screeners

Risks to This Prediction

• A rebound above the previous close of 28,896.10 would soften the cautious view.
• A move below the low of 28,632.35 would signal deeper selling.
• US pricing or regulatory news can move the group sharply.

Readers comparing views should note that this nifty pharma prediction for tomorrow draws only on Wednesday's closing numbers and the factors listed here.

As with any nifty pharma prediction for tomorrow, the opening minutes of Thursday's trade will confirm or challenge the levels discussed here.

Download the Univest iOS App or Univest Android App to get daily market recommendations and insightful research pieces.

Conclusion

The nifty pharma prediction for tomorrow leans mildly cautious into 12 November 2026, with US pricing commentary and the Nifty 50 as the key variables to track. Ankit Jaiswal and Kunal Singla will revisit this view once Thursday's opening trade confirms direction.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

Frequently Asked Questions

What is the nifty pharma prediction for tomorrow?

Ans. It is mildly cautious for 12 November 2026, after Nifty Pharma fell 0.41 percent to 28,776.45 on Wednesday.

Why is this a prediction for tomorrow, 12 November 2026?

Ans. Because this note is published on Wednesday, 11 November 2026, after the close, and the next regular trading session is tomorrow, Thursday, 12 November 2026. There is no exchange holiday on that date.

Why did Nifty Pharma fell on Wednesday?

Ans. Nifty Pharma fell 0.41 percent to 28,776.45. The specific trigger was not independently confirmed.

What levels matter for Nifty Pharma tomorrow?

Ans. Support sits near 28,632.35. Resistance sits near 28,896.10, 29,187.55 and 29,187.65.

Is this a buy or sell call?

Ans. No. This is an educational outlook from Univest's research team, not a buy or sell call. Traders should check any view against their own risk plan before acting.